London blue-chips edge higher ahead of busy week of earnings
London's blue chip index edged higher on Tuesday, with its largest constituent AstraZeneca supporting gains, as investor heads turn to the US Federal Reserve's interest rate decision due Wednesday. 'It's a busy week for corporate earnings in the UK and US, and investors have plenty of news to digest. The latest set of UK results were generally well-received,' said Russ...